Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma
European Radiology · 2024
DOI: 10.1007/s00330-024-10948-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, 2024. Verfasst von Qi Yong H Ai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong S.A.R., P.R. China. Hauptthemen laut MEDLINE: Nasopharyngeal Neoplasms, Nasopharyngeal Carcinoma, Magnetic Resonance Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To investigate the potential of T1rho, a new quantitative imaging sequence for cancer, for pre and early intra-treatment prediction of treatment response in nasopharyngeal carcinoma (NPC) and compare the results with those of diffusion-weighted imaging (DWI). Materials and methods T1rho and DWI imaging of primary NPCs were performed pre- and early intra-treatment in 41 prospectively recruited patients. The mean preT1rho, preADC, intraT1rho, intraADC, and % changes in T1rho (ΔT1rho%) and ADC (ΔADC%) were compared between residual and non-residual groups based on biopsy in all patients after chemoradiotherapy (CRT) with ( n = 29) or without ( n = 12) induction chemotherapy (IC), and between responders and non-responders to IC in the subgroup who received IC, using Mann–Whitney U -test. A p -value of < 0.05 indicated statistical significance.
Results
Significant early intra-treatment changes in mean T1rho ( p = 0.049) and mean ADC ( p < 0.01) were detected (using paired t -test), most showing a decrease in T1rho (63.4%) and an increase in ADC (95.1%). Responders to IC ( n = 17), compared to non-responders ( n = 12), showed higher preT1rho (64.0 ms vs 66.5 ms) and a greater decrease in ΔT1rho% (− 7.5% vs 1.3%) ( p < 0.05). The non-residual group after CRT ( n = 35), compared to the residual group ( n = 6), showed higher intraADC (0.96 vs 1.09 × 10 −3 mm 2 /s) and greater increase in ΔADC% (11.7% vs 27.0%) ( p = 0.02).
Conclusion
Early intra-treatment changes are detectable on T1rho and show potential to predict tumour shrinkage after IC. T1rho may be complementary to DWI, which, unlike T1rho, did not predict response to IC but did predict non-residual disease after CRT. Clinical relevance statement T1rho has the potential to complement DWI in the prediction of treatment response. Unlike DWI, it predicted shrinkage of the primary NPC after IC but not residual disease after CRT. Key Points Changes in T1rho were detected early during cancer treatment for NPC . Pre-treatment and early intra-treatment change in T1rho predicted response to IC, but not residual disease after CRT . T1rho can be used to complement DWI with DWI predicting residual disease after CRT .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong S.A.R., P.R. China.
- Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong S.A.R., P.R. China.
- Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong S.A.R., P.R. China. king2015@cuhk.edu.hk.
- Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong S.A.R., P.R. China.
- State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong S.A.R., P.R. China.
- Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong S.A.R., P.R. China.
Zitieren
APA
Ai, Q. Y. H., King, A. D., Tsang, Y. M., Yu, Z., Mao, K., Mo, F. K. F., Wong, L. M., Leung, H. S., So, T. Y., Hui, E. P., Ma, B. B. Y., & Chen, W. (2024). Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma. European Radiology. https://doi.org/10.1007/s00330-024-10948-5
Vancouver
Ai QYH, King AD, Tsang YM, Yu Z, Mao K, Mo FKF, et al. Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma. European Radiology. 2024. doi:10.1007/s00330-024-10948-5
BibTeX
@article{Ai2024,
author = {Ai, Qi Yong H and King, Ann D and Tsang, Yip Man and Yu, Ziqiang and Mao, Kaijing and Mo, Frankie K F and Wong, Lun M and Leung, Ho Sang and So, Tiffany Y and Hui, Edwin P and Ma, Brigette B Y and Chen, Weitian},
title = {Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma},
journal = {European Radiology},
year = {2024},
doi = {10.1007/s00330-024-10948-5}
}
EUVIMED